USPTO serial 79290707
AVANCE CLINICAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 9, 2021
- Examiner
- KELLEY, EVELYN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with AVANCE CLINICAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
AU
AU
AU
AU
AU
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David L. May
David L. May NIXON PEABODY LLP799 9TH STREET, NW, SUITE 500WASHINGTON, DC 20001UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Advisory services relating to pharmacology; advisory services relating to product testing; advisory services relating to science in the field of pharmacology; advisory services relating to scientific research; development of software systems for the processing of data; development of testing methods in the field of pharmacology; conducting clinical trials for others; conducting clinical trials for others in the field of pharmacology; conducting technical project studies in the field of pharmacology; consultancy pertaining to pharmacology; medical research; pharmaceutical research services; preparation of reports relating to scientific research; preparation of statistics for scientific research, namely, preparation of technical reports and analyses of statistical data for scientific research; provision of information relating to scientific research; Product quality testing; research relating to biotechnology; research relating to data processing; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of pharmacology; scientific consultancy services relating to pharmacology; scientific testing services in the field of pharmacology; services for assessing the efficiency of pharmaceuticals; services for assessing the safety of pharmaceuticals; technical data analysis services in the field of pharmacology; testing of products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks owned by Avance Clinical Pty Ltd
- Other trademarks in Class 042
- Similar marks named AVANCE CLINICAL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 17, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 28, 2022 | FINA | FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Feb 9, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 29, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 9, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 24, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 24, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 22, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 4, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 4, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 4, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 22, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 17, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| May 17, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 11, 2021 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Mar 11, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 5, 2021 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 5, 2021 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 14, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 6, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 5, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 7, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 30, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |